Open AccessIn-Hospital Outcome of Patients with Acute ST-Segment Elevation Myocardial Infarction Who Did Not Receive Reperfusion Therapy at Our Institute
Author(s) -
Shahid Hussain Memon,
Ghulam Fareed Shah,
Gul Hassan Brohi,
Abdul Ghaffar Memon,
Jagdesh Kumar,
Anwar Ali
Publication year - 2021
Publication title -
journal of pharmaceutical research international
Language(s) - English
Resource type - Journals
ISSN - 2456-9119
DOI - 10.9734/jpri/2021/v33i30b31637
Subject(s) - medicine , reperfusion therapy , myocardial infarction , chest pain , diabetes mellitus , cohort , emergency medicine , pediatrics , endocrinology
Objective: This study aims to determine the in-hospital outcome of patients with acute ST-segment elevation myocardial infarction who did not receive reperfusion therapy at our institute.
Methodology: Cohort of patients recruited from Emergency Department of Liaquat University Hospital, Hyderabad affiliated with Liaquat University of Medical & Health sciences, Jamshoro, Sindh, Pakistan from August 2nd, 2019 to 1st July 2020. All the patients who were diagnosed as a case of acute STEMI belongs to any age group of either gender and who did not receive reperfusion therapy either percutaneous or pharmacological therapy due to any cause were included in our study to assess their in-hospital outcome.
Results: Total of 106 patients were enrolled having mean age and SD of 51.09 ± 13.50 years in which 67.92% were males. Significantly higher proportion of patients who did not receive reperfusion therapy died during hospitalization (27.35%, N = 29). The most common risk factors associated with higher mortality rates were increasing age, increased mean duration of hospitalization from the onset of chest pain, raised RBS, diabetes mellitus, and smoking, p <0.001.
Conclusion: Almost one third of patients with acute STEMI who did not receive reperfusion therapy were died during hospitalization. Among those, unfortunately the higher mortality was observed having modifiable risk factors.